Harold Whitman
Director of R&D and Technical Strategy
Combining advanced engineering technology with the RWA ecosystem to deliver safer, more efficient financial solutions.
Biography
Dr. Harold Whitman serves as Director of Research and Development at PrimePrix Capital. He holds a Ph.D. in Bioengineering from the Massachusetts Institute of Technology (MIT), bringing a world-class scientific perspective to Real-World Assets (RWA) and algorithmic trading.
Dr. Whitman currently advises several international medical engineering organizations and leads the integration of complex real-world asset data technologies into the PrimePrix Nova digital infrastructure. At PrimePrix Capital, he oversees the R&D Lab, ensuring the integrity of RWA-backed protocols and advancing the integration of next-generation medical technologies with the platform ecosystem. His work keeps PrimePrix Nova at the intersection of high-precision engineering and digital asset transparency.

